Aesthetic Injectable Market Size To Reach $24.1 Billion By 2033

Aesthetic Injectable Market Growth & Trends

The global aesthetic injectable market size is expected to reach USD 24.1 billion by 2033, registering a CAGR of 10.0% from 2026 to 2033, according to a new report by Grand View Research, Inc. The industry is experiencing notable growth driven by several factors. These include increasing consumer awareness about minimally invasive cosmetic procedures, advancements in injectable technologies, and rising demand for non-surgical aesthetic enhancements.

Technological and research progress has led to the development of inventive injectable formulations, expanding the market's offerings to include various products addressing precise concerns like fine lines, wrinkles, volume loss, and skin texture. For instance, according to the National Center for Biotechnology and Information (NCBI) in January 2024, the injectable Sculptra Poly-L-Lactic Acid (PLLA-SCA) treatments were well received and notably diminished the severity of moderate to severe wrinkles and cheek lines while enhancing skin quality. Their effectiveness remained consistent throughout the 12-month study, with subjects reporting high satisfaction, achieving a natural appearance, and expressing eagerness for further treatments.

Additionally, shifting beauty standards and a growing aging population contribute to market expansion. Moreover, the availability of a wide range of injectable products, coupled with innovative marketing strategies by key players, further stimulates market growth. Furthermore, favorable regulatory frameworks and an expanding network of aesthetic clinics and medical spas are fostering the uptake of aesthetic injectables worldwide.

 Request a free sample copy or view report summary: Aesthetic Injectable Market Report

Aesthetic Injectable Market Report Highlights

• By product, the botulinum toxin (Botox) segment held the largest market share of 44.5% in 2025. The PN/PDRN segment is expected to grow at the fastest CAGR of 16.9% over the forecast period.

• By application, the wrinkle correction segment held a leading market share in 2025. The lip augmentation segment is expected to grow at the fastest CAGR over the forecast period.

• By end-use, the medspas segment held a leading market share in 2025. The aesthetic surgery centers segment is anticipated to grow at the second-fastest CAGR over the forecast period.

• The North America aesthetic injectable market held the largest global share of 40.1% in 2025. The U.S. aesthetic injectable industry is expected to grow significantly from 2026 to 2033.

• The Asia Pacific aesthetic injectable industry is gaining traction and is expected to grow at the fastest CAGR of 11.9% during the forecast period.

Aesthetic Injectable Market Segmentation

Grand View Research has segmented global aesthetic injectable market report based on product, application, end-use, and region:

Aesthetic Injectable Product Outlook (Revenue, USD Million, 2021 - 2033)

• Collagen and PMMA Microspheres

• Hyaluronic Acid

  • Monophasic

  • Biphasic

• Calcium Hydroxylapatite (CaHA)

• PLLA

• PCL

• PN/PDRN

• Botulinum Toxin (Botox)

Aesthetic Injectable Application Outlook (Revenue, USD Million, 2021 - 2033)

• Wrinkle Correction

• Lip Augmentation

• Facial Contouring

• Scar Treatment

• Volume Loss Restoration

• Others

Aesthetic Injectable End-use Outlook (Revenue, USD Million, 2021 - 2033)

• MedSpas

• Aesthetic Surgery Centers

• Hospitals

• Others

Aesthetic Injectable Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

  • Russia

• Asia Pacific

  • China

  • Japan

  • South Korea

  • Thailand

  • Australia

  • Singapore

  • Malaysia

  • Taiwan

  • India

  • Vietnam

  • Philippines

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Aesthetic Injectable Market

• AbbVie Inc

• Galderma

• Merz GmbH and Co. KGaA

• Sinclair

• Medytox

• Prollenium Medical Technologies

• Tiger Aesthetics Medical (Suneva Medical, Inc.)

• HUGEL, Inc.

• Ipsen Pharma

• Teoxane